NBIX – neurocrine biosciences, inc. (US:NASDAQ)
Stock Stats
News
Neurocrine Biosciences (NBIX) was upgraded by Wolfe Research to "strong-buy".
Neurocrine Biosciences to Present at Upcoming Investor Conferences in March [Yahoo! Finance]
Neurocrine Biosciences to Present at Upcoming Investor Conferences in March
Neurocrine Biosciences (NASDAQ:NBIX) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $160.00 price target on the stock.
Neurocrine Biosciences (NASDAQ:NBIX) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Form 4 NEUROCRINE BIOSCIENCES For: Feb 20 Filed by: Onyia Jude
Form 4 NEUROCRINE BIOSCIENCES For: Feb 12 Filed by: Boyer David W.
Form 4 NEUROCRINE BIOSCIENCES For: Feb 12 Filed by: ABERNETHY MATT
Form 4 NEUROCRINE BIOSCIENCES For: Feb 12 Filed by: Gano Kyle
Form 4 NEUROCRINE BIOSCIENCES For: Feb 12 Filed by: Onyia Jude
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.